CTOs on the Move


 
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Sybron Dental Specialties, Inc.

Sybron Dental Specialties, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Anaheim, CA. To find more information about Sybron Dental Specialties, Inc., please visit www.sybrondental.com

MedRisk

MedRisk is the leading provider of managed physical medicine for the workers` compensation industry and related market sectors. Unified through a uniquely integrated, US-based support model, we pride ourselves in combining clinical expertise with highly personal service and responsiveness. This focus allows us to offer distinct value to each stakeholder in the workers` comp process – carriers and TPAs, employers, adjusters and case managers, physicians, network providers and the patients themselves. In short, we`re here for you; at MedRisk, you`re never just a number – you`re an individual who deserves a solution tailored to your exact needs. We`re here to help you reach your goals and improve your outcomes – whatever they may be.

The Saginaw County Community Mental Health Authority

Saginaw County Community Mental Health Authority (SCCMHA) is a local, independent governmental unit that provides for the publicly funded mental health needs of all eligible persons in Saginaw County.

Johnson Memorial Hospital (IN)

Johnson Memorial Hospital (IN) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Johnson Memorial Hospital (IN) is based in Franklin, IN. You can find more information on Johnson Memorial Hospital (IN) at www.johnsonmemorial.org

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.